Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Vir Biotechnology, Inc. market cap for the quarter ending 2026-07-29 was $1.46B, a 101.47% increase year-over-year.
Vir Biotechnology, Inc. market cap for the quarter ending 2026-06-30 was $1.72B, a 146.29% increase year-over-year.
Vir Biotechnology, Inc. market cap for the quarter ending 2026-04-29 was $1.7B, a 101.14% increase year-over-year.
Vir Biotechnology, Inc. market cap for the quarter ending 2026-03-31 was $1.44B, a 61.48% increase year-over-year.
Vir Biotechnology, Inc. market cap for fiscal 2026 was $1.46B.
Vir Biotechnology, Inc. market cap for fiscal 2025 was $841.03M, a 16.34% decline from fiscal 2024.
Vir Biotechnology, Inc. market cap for fiscal 2024 was $1.01B, a 25.86% decline from fiscal 2023.
Vir Biotechnology, Inc. market cap for fiscal 2023 was $1.36B, a 59.79% decline from fiscal 2022.